Datacreds Revolutionizes Pharmacovigilance with Crypta: Automated Local Literature Monitoring for Non-Indexed Sources

• Crypta, A Local Literature Monitoring Platform delivers results up to 20 times faster than conventional methods, with greater accuracy and consistency.

• Now live with a leading global pharmaceutical company, this fully managed service leverages a proprietary ingestion model developed by Datacreds to close a long-standing gap in pharmacovigilance practices.

• Local literature surveillance, a regulatory must-have with high operational costs and low yield, is now significantly streamlined.

Datacreds, a pioneer in AI-driven pharmacovigilance technologies, has launched Crypta - A Local Literature Platform, a breakthrough automation solution that addresses one of the industry’s toughest challenges: efficiently identifying adverse events from non-indexed, local, and region-specific publications.

This end-to-end managed service, already deployed at 15 pharmaceutical company, tackles a critical blind spot in safety surveillance. Many adverse events first surface through niche local publications and country-specific online sources — often missed by global literature databases. Regulatory agencies mandate comprehensive local screening, making this an essential yet resource-draining task.

With Crypta, the game changes:

• Manual and error-prone processes are replaced by a tech-enabled, highly scalable system.

• Built-in machine translation, intelligent crawlers, and country-level filtering enable real-time monitoring across all geographies.

• Even hard-to-access sources — including print journals, conferences, and subscription-only content — are systematically captured.

• Results are validated by expert reviewers to ensure compliance-readiness and auditability.

Crypta leverages advanced ingestion algorithms developed by Datacreds’ engineering team. Each source is evaluated and connected through automated crawlers tailored for that country or source type, ensuring no critical safety signal is missed. The system also complements the broader Crypta Platform, which unifies indexed and non-indexed literature surveillance into a single, powerful interface.

This innovation brings together the strengths of automation, intelligent data handling, and human oversight — creating a robust, audit-ready solution that significantly boosts patient safety outcomes.

Key capabilities of Crypta Local Literature include:

• End-to-end automation across all countries

• Multilingual support with automated translations

• Country-level safety data filtering

• Unified search across global and local sources

• Full audit trail and regulatory compliance features

Head of Pharmacovigilance of a Pharma company, commented:

“With Crypta, we’re solving a problem that’s plagued the industry for years. Our approach balances innovation with compliance — we’re not just automating for speed, we’re ensuring that the data is accurate, reliable, and regulator-ready. This is a major leap forward for pharmacovigilance and global patient safety.”

To learn more about Crypta Local Literature, schedule a demo.

About Datacreds

Datacreds is at the forefront of pharmacovigilance automation, delivering scalable, intelligent solutions for literature review, ICSR processing, and signal detection. The Crypta Platform transforms traditional workflows with AI-powered tools, enabling life sciences organizations to meet global compliance standards efficiently. Datacreds is 21 CFR Part 11 compliant and adheres to GxP and ISO 27001 standards.